T1	Intervention 140 465	OBJECTIVE We evaluated the effects of a new combined hormonal contraceptive vaginal ring (CVR) delivering the nonandrogenic progestin Nestorone (NES) and ethinyl estradiol (EE) on several key estrogen-sensitive hepatic proteins that may be markers for the risk of arterial or venous disease events and on blood pressure (BP).
T2	Intervention 1780 1788	repeated
T3	Intervention 2551 2562	differences
T4	Intervention 894 898	with
T5	Intervention 1245 1250	third
